Sublingual drops are easy
An IM injection delivers medicine directly into a muscle rather than under the skin, allowing faster absorption and avoiding some of the delays or limits of oral or subcutaneous routes
Response to certolizumab pegol in the RAPID-PsA trial was comparable to other TNF inhibitors in PsA, with 58% of the certolizumab pegol 200 mg every-2-weeks group and 51.9% of the certolizumab pegol 400 mg every-4-weeks group achieving an ACR20 at 12 weeks compared with 24.3% in the placebo arm (Figure 7-16)
Six weeks in, I was back to work without constantly popping ibuprofen
Constipation management strategies that work for GLP-1 users, fiber supplementation, adequate hydration, and mild osmotic laxatives, apply equally to cagrilintide protocols
Mistake 4: inconsistent dosing Missing doses, varying amounts, or irregular timing all reduce effectiveness